Matinas BioPharma Holdings Inc To Discuss The Business Outlook Call Transcript
Hello, and welcome to the Matinas BioPharma 2023 Business Update and Strategic Outlook Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the conference over to Dr. Ankit Bhargava, Investor Relations representative for Matinas BioPharma. You may begin.
Thank you, Kevin. Good afternoon, everyone, and thank you for joining with Matinas BioPharma 2023 Business Update and Strategic Outlook Conference Call. Earlier this afternoon, we issued a press release with our preliminary financial results, along with business substates. The release is available on the Matinas BioPharma website under the Investors section.
There are accompanying slides in today's presentation, which are available by joining the web through the Investor section of the company website. Speaking on today's call will be Jerry Jabbour, Chief Executive Officer. We also have Mr. Thomas Hoover, Chief Business Officer; Dr. Terry Matkovits,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
